Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 12Vomiting 7Uterine Cervical Neoplasms 5Neoplasms 5Nausea 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Carcinoma, Ovarian Epithelial 4Multiple Myeloma 3Testicular Neoplasms 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neuroblastoma 2Myeloproliferative Disorders 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2

Interventions

Carboplatin 3Bevacizumab 3olaparib 2niraparib 2anlotinib 2Paclitaxel 2Diet, Mediterranean 2Blood Specimen Collection 2temsirolimus 1relacorilant 1pembrolizumab 1nintedanib 1liposomal doxorubicin 1lenvatinib 1entinostat 1avelumab 1Trabectedin 1Tissue Banks 1Papanicolaou Test 1Ocoxin 1NUC-1031 1Gemcitabine 1Food, Formulated 1Filgrastim 1Diffusion 1Dexamethasone 1Cell Count 1CP protocol 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Diseases × Dexamethasone × Gynecologic × Clear all
NCT00050414 2013-01-10

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
147 enrolled
Gynecologic

Adnexal Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡